Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial

The Swiss Group for Clinical Cancer Research (SAKK) conducted the SAKK 35/03 randomized trial (NCT00227695) to investigate different rituximab monotherapy schedules in patients with follicular lymphoma (FL). Here, we report their long-term treatment outcome. Two-hundred and seventy FL patients were...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Moccia, Alden A., Taverna, Christian, Schär, Sämi, Vanazzi, Anna, Rondeau, Stéphanie, Hitz, Felicitas, Mingrone, Walter, Pabst, Thomas, Cevreska, Lidija, del Giglio, Auro, Raats, Johann, Rauch, Daniel, Vorobiof, Daniel A., Lohri, Andreas, Ruegsegger, Céline, Biaggi Rudolf, Christine, Rusterholz, Corinne, Hayoz, Stefanie, Ghielmini, Michele, Zucca, Emanuele
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724909/
https://ncbi.nlm.nih.gov/pubmed/33275769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002858
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados